Clarivate CLVT Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Academia & Government Group | $295M-5.5% | $312.3M-6.1% | $332.5M+4.4% | $318.5M+5.2% | $302.7M-11.7% | |
| Intellectual Property Group | $197.2M-4.5% | $206.4M+4.3% | $197.8M-2.3% | $202.5M+5.1% | $192.7M-7.8% | |
| Life Sciences & Healthcare | $93.3M-5.1% | $98.3M+5.9% | $92.8M-7.6% | $100.4M+2.1% | $98.3M-11.4% | |
| Royalty And Other Product Expense by Business | ||||||
| Academia & Government Group | $45.1M-4.4% | $47.2M-24.7% | $62.7M+24.4% | $50.4M-8.5% | $55.1M-21.2% | |
| Intellectual Property Group | $15.9M-21.7% | $20.3M+13.4% | $17.9M-7.3% | $19.3M+7.2% | $18M-10.9% | |
| Life Sciences & Healthcare | $8.8M-8.3% | $9.6M+1.1% | $9.5M+1.1% | $9.4M+6.8% | $8.8M-12.9% | |
| Other Cost and Expense, Operating by Business | ||||||
| Academia & Government Group | $9.7M-40.1% | $16.2M+37.3% | $11.8M+13.5% | $10.4M+16.9% | $8.9M-7.3% | |
| Intellectual Property Group | $5.7M+9.6% | $5.2M-14.8% | $6.1M-14.1% | $7.1M+36.5% | $5.2M-16.1% | |
| Life Sciences & Healthcare | $3M+100% | $1.5M-55.9% | $3.4M+13.3% | $3M+20.0% | $2.5M+4.2% | |
| Adjusted EBITDA by Business | ||||||
| Academia & Government Group | $126.6M-4.9% | $133.1M-9.0% | $146.3M+1.0% | $144.8M+17.0% | $123.8M-16.6% | |
| Intellectual Property Group | $85.4M-3.9% | $88.9M+8.7% | $81.8M-3.3% | $84.6M+7.4% | $78.8M-17.3% | |
| Life Sciences & Healthcare | $29.2M-10.4% | $32.6M+34.2% | $24.3M-24.5% | $32.2M+5.2% | $30.6M-26.4% | |
| Technology Expenses by Business | ||||||
| Academia & Government Group | $21M+6.1% | $19.8M+2.1% | $19.4M-3.0% | $20M+2.0% | $19.6M-2.0% | |
| Intellectual Property Group | $12.8M+2.4% | $12.5M-7.4% | $13.5M+7.1% | $12.6M+2.4% | $12.3M+5.1% | |
| Life Sciences & Healthcare | $6.6M-5.7% | $7M-12.5% | $8M+21.2% | $6.6M-5.7% | $7M-2.8% | |
| Outside Service Expense by Business | ||||||
| Academia & Government Group | $7.3M-12.0% | $8.3M+9.2% | $7.6M-13.6% | $8.8M-3.3% | $9.1M-10.8% | |
| Intellectual Property Group | $4.2M-14.3% | $4.9M-3.9% | $5.1M-1.9% | $5.2M-8.8% | $5.7M-5.0% | |
| Life Sciences & Healthcare | $2M-28.6% | $2.8M+27.3% | $2.2M-26.7% | $3M+15.4% | $2.6M-18.8% | |
| People-Related Expenses by Business | ||||||
| Academia & Government Group | $85.3M-2.7% | $87.7M+3.5% | $84.7M+0.7% | $84.1M-2.4% | $86.2M+1.7% | |
| Intellectual Property Group | $73.2M-1.9% | $74.6M+1.6% | $73.4M-0.4% | $73.7M+1.4% | $72.7M+4.3% | |
| Life Sciences & Healthcare | $43.7M-2.5% | $44.8M-1.3% | $45.4M-1.7% | $46.2M-1.3% | $46.8M+0.6% | |
| Restructuring costs by Business | ||||||
| Academia & Government Group | $4.8M+269% | $1.3M-60.6% | $3.3M-23.3% | $4.3M-65.0% | $12.3M+720% | |
| Intellectual Property Group | $4.1M+36.7% | $3M-31.8% | $4.4M+144% | $1.8M-72.3% | $6.5M+150% | |
| Life Sciences & Healthcare | $3.1M+520% | $500K-88.1% | $4.2M+31.3% | $3.2M-45.8% | $5.9M+392% | |
| Revenue by Product | ||||||
| Re-occurring Revenues | $108.6M-4.8% | $114.1M+8.4% | $105.3M-3.3% | $108.9M+2.8% | $105.9M-5.4% | |
| Recurring Revenues | $506.1M— | —— | —— | —— | $494.5M-3.8% | |
| Subscription revenues | $397.5M-2.0% | $405.8M+0.1% | $405.4M-0.1% | $405.7M+4.4% | $388.6M-4.5% | |
| Transactional and other revenues | $79.4M-18.2% | $97.1M-13.6% | $112.4M+5.2% | $106.8M+7.7% | $99.2M-31.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Clarivate break its business down?
- Clarivate (CLVT) reports revenue by business across 3 parts — Academia & Government Group, Intellectual Property Group and Life Sciences & Healthcare. Each is extracted from the segment footnotes and tracked over time.
- Where does Clarivate's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Clarivate's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
